June 27 and 28 in Trieste (Italy), a two-day event dedicated to hemophilia
Replacement therapy, personalization and access to treatment are the main themes of the congress organized by Kedrion
16th International Hemophilia Congress in Turkey
A scientific symposium on the prevention and eradication of inhibitors in patients affected by Hemophilia A
Kedrion renews its commitment to PID patients at ESID 2018
18th edition of the Biennial Meeting of the European Society for Immunodeficiencies helds in Lisbon (Oct. 24 to 27)
50 years of Anti-D celebrated at World Congress of Gynecology and Obstetrics in Rio De Janeiro
Kedrion supports educational symposium to help Rh disease awareness and eradication
EIGHT, the global educational initiative on Hemophilia A and its treatment
Experts from all over the world attended the EIGHT 2018 Conference in Budapest, Hungary on 12-13 October
Kedrion Biopharma participates in the Mother and Child Conference in Moscow
A 50 years of Anti-D dedicated programme presented at the main Russian congress of Gynecology and Obstetrics
Kedrion Joins Annual PNS Conference on Neurology
The company took part in the event with a booth and a delegation of 40 int’l guests
Kedrion Biopharma celebrates Primary Immunodeficiency Week
The company stands alongside PI patients associations around the globe
Kedrion Biopharma celebrates World Hemophilia Day 2018
Support for patients with coagulation disorders worldwide is confirmed
50-Year Anniversary of a Maternal Health Breakthrough
Kedrion Biopharma supports session on Anti-D achievements and challenges at FIGO Congress in Dubai